SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-18-335247
Filing Date
2018-11-27
Accepted
2018-11-27 16:29:02
Documents
6
Period of Report
2018-11-21
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 2.03: Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant
Item 2.04: Triggering Events That Accelerate or Increase a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K d595829d8k.htm 8-K 24488
2 EX-10.1 d595829dex101.htm EX-10.1 1753983
3 EX-99.1 d595829dex991.htm EX-99.1 7509
4 EX-99.2 d595829dex992.htm EX-99.2 20985
5 GRAPHIC g595829g18k28.jpg GRAPHIC 2602
6 GRAPHIC g595829g68l65.gif GRAPHIC 2146
  Complete submission text file 0001193125-18-335247.txt   1815370
Mailing Address 2150 ST. ELZEAR BLVD. WEST LAVAL QUEBEC A8 H7L 4A8
Business Address 2150 ST. ELZEAR BLVD. WEST LAVAL QUEBEC A8 H7L 4A8 514-744-6792
Bausch Health Companies Inc. (Filer) CIK: 0000885590 (see all company filings)

IRS No.: 000000000 | State of Incorp.: NJ | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-14956 | Film No.: 181203336
SIC: 2834 Pharmaceutical Preparations
Assistant Director 1